Maria Hannaway, MD
Dermatology · Paoli, PANPI 1265843304
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $95,725 of the $96,494 with a category attached, or 99.2%. Incyte Corporation accounts for 99.2% of it on its own, with 7 other manufacturers making up the rest. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $1892.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$96K
- AbbVie$450
- Merz North America, Inc.$135
- Johnson & Johnson$72
- Amgen$38
- E.r. Squibb & Sons, L.L.C.$38
- plus $36 from 2 others
What the payments were for
- Consulting fees$95,72599%
- Food & beverage$6971%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 11 | $95,725 |
| AbbVie(2 entities) | 30 | $450 |
| Merz North America, Inc. | 3 | $135 |
| Johnson & Johnson | 1 | $72 |
| Amgen | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| UCB, Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$122
How this compares
$96,494 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 25 | $6,353 |
| Pimecrolimus | 15 | $3,833 |
| Clobetasol Propionate | 86 | $3,411 |
| Ketoconazole | 88 | $1,637 |
| Betamethasone Dipropionate | 29 | $1,289 |
| Metronidazole | 27 | $1,072 |
| Triamcinolone Acetonide | 55 | $640 |
| Fluocinolone Acetonide | 15 | $458 |
| Clindamycin Phosphate | 11 | $245 |
| Mupirocin | 14 | $216 |
| Minoxidil | 16 | $190 |
| Hydrocortisone | 16 | $93 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Paoli
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.